Ebglyss

Active Ingredient(s): Lebrikizumab-lbkz
FDA Approved: * September 13, 2024
Pharm Company: * ELI LILLY AND CO
Category: Skin Care
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Ebglyss 250 mg/2ml Subcutaneous Injection, Solution
NDC: 0002-7772
Labeler:
Eli Lilly and Company
Ebglyss 250 mg/2ml Subcutaneous Injection, Solution
NDC: 0002-7797
Labeler:
Eli Lilly and Company